These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 4315663)

  • 21. [Toxin formation by Cl. perfringens type E].
    Zemlianitskaia EP; Matveev KI; Tsurikov FF
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jul; 43(7):86-90. PubMed ID: 4307060
    [No Abstract]   [Full Text] [Related]  

  • 22. [Localization of phosphatases in Clostridium perfringens cells].
    Kachelkina AI; Kushnarev VM; Blagoveshchenskiĭ VA
    Dokl Akad Nauk SSSR; 1967 May; 174(3):700-3. PubMed ID: 4317618
    [No Abstract]   [Full Text] [Related]  

  • 23. [Phospholipid-splitting enzymes. 2].
    Matsumoto M; Tamiya K; Suzuki Y; Miwa M
    Tanpakushitsu Kakusan Koso; 1969 Aug; 14(9):811-22. PubMed ID: 4310951
    [No Abstract]   [Full Text] [Related]  

  • 24. [Toxin formation by Cl. perfringens on a casein-pancreatic medium].
    Urguev KR; Kirillov LV; Liubich FD; Lavchenko EG; Panfilov ID
    Veterinariia; 1973 Feb; 49(2):39-40. PubMed ID: 4356903
    [No Abstract]   [Full Text] [Related]  

  • 25. [Lipase and tweenase activity of Cl. perfringens and Cl. botulinum].
    Blagoveshchenskiĭ VA; Tikhaze AK; Borishpolets ZI
    Biull Eksp Biol Med; 1972 Aug; 73(8):74-7. PubMed ID: 4344071
    [No Abstract]   [Full Text] [Related]  

  • 26. Complementation of theta-toxinogenicity between mutants of two groups of Clostridium perfringens.
    Higashi Y; Chazono M; Inoue K; Yanagase Y; Amano T
    Biken J; 1973 Mar; 16(1):1-9. PubMed ID: 4354118
    [No Abstract]   [Full Text] [Related]  

  • 27. Significance of beta 2-toxigenic clostridium perfringens infections in animals and their predisposing factors--a review.
    Schotte U; Truyen U; Neubauer H
    J Vet Med B Infect Dis Vet Public Health; 2004 Dec; 51(10):423-6. PubMed ID: 15606864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Study of acid soluble phosphate compounds from Clostridium perfringens].
    Maĭorova IP; Blagoveshchenskiĭ VA
    Biokhimiia; 1967; 32(2):329-36. PubMed ID: 4298442
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative study of the process of activation and potentiation in mixtures of sterile and o-sterile toxins, type A, of Cl. perfringens and Cl. oedematiens].
    Zhak SP
    Mikrobiol Zh; 1968; 30(4):321-5. PubMed ID: 4308320
    [No Abstract]   [Full Text] [Related]  

  • 30. [Observations of potentiation of toxins of Clostridium perfringens and Clostridium histolyticum].
    Mitskevich AI
    Mikrobiol Zh; 1967; 29(2):125-9. PubMed ID: 4308692
    [No Abstract]   [Full Text] [Related]  

  • 31. Some properties of heat-resistant and heat-sensitive strains of Clostridium perfringens. I. Heat resistance and toxigenicity.
    Weiss KF; Strong DH
    J Bacteriol; 1967 Jan; 93(1):21-6. PubMed ID: 4289809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuraminidase in the cells and toxins of Cl. perfringens].
    Ispolatovskaia MV; Tokinova TN; Cherikovskaia EN; Borishpolets ZI
    Vopr Med Khim; 1973; 19(1):49-54. PubMed ID: 4362796
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of calcium on the production of various toxins of Clostridium perfringens.
    Soda S; Sato H; Murata R
    Jpn J Med Sci Biol; 1969 Jun; 22(3):175-9. PubMed ID: 4310349
    [No Abstract]   [Full Text] [Related]  

  • 34. Three-dimensional structure of a putative non-cellulosomal cohesin module from a Clostridium perfringens family 84 glycoside hydrolase.
    Chitayat S; Gregg K; Adams JJ; Ficko-Blean E; Bayer EA; Boraston AB; Smith SP
    J Mol Biol; 2008 Jan; 375(1):20-8. PubMed ID: 17999932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An electron microscopic study of the fine structure of toxigenic and weakly toxigenic strains of Cl. perfringens].
    Pavlova IB; Larina IA
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Aug; 46(8):9-12. PubMed ID: 4311981
    [No Abstract]   [Full Text] [Related]  

  • 36. Peptides for toxinogenesis of Clostridium perfringens type D.
    Hauschild AH
    J Bacteriol; 1965 Dec; 90(6):1793-4. PubMed ID: 4285335
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effect of proteolytic enzymes on the activation of the prototoxins of Cl. perfringens types D and E].
    Zemlianitskaia EP; Matveev KI
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Aug; 46(8):57-60. PubMed ID: 4311980
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunopurification of phospholipase C (alpha-toxin) from Clostridium perfringens.
    Bird RA; Low MG; Stephen J
    FEBS Lett; 1974 Aug; 44(3):279-81. PubMed ID: 4370089
    [No Abstract]   [Full Text] [Related]  

  • 39. Continuous production of L-citrulline by immobilized Pseudomonas putida cells.
    Yamamoto K; Sato T; Tosa T; Chibata I
    Biotechnol Bioeng; 1974 Dec; 16(12):1589-99. PubMed ID: 4441633
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of molasses and whey in culture media for the development and production of a toxin from Clostridium perfringens type D].
    Silva HJ; Giulietti AM; Segovia RF; Ertola RJ
    Rev Argent Microbiol; 1982; 14(2):85-90. PubMed ID: 6101000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.